ORMDL3 and metabolic dysfunction-associated steatohepatitis: Analysis of differentially expressed mRNAs among healthy controls and NASH patients using publicly available data (GSE89632) [45] revealed that hepatic expression of ORMDL3, but not ORMDL1 or ORMDL2, were significantly upregulated in male but not female NASH samples compared to healthy controls.